Libigel

Libigel Directory

BioSante presents validation records for LibiGel

TradingMarkets New for BPA - BioSante presents validation records for LibiGel. Let Larry Connors and the Connors Research team show you the route to more successful trading.
www.tradingmarkets.com/.site/news/Stock%20News/682677/ - 114k - 14 Feb 2008 - Cached - Similar pages

BioSante Pharmaceuticals Announces FDA Clarity on Development of ...

The primary focus of the meeting was BioSanteâ€™s LibiGel safety study protocol to evaluate the cardiovascular risk of using testosterone in women, a key pre-approval concern of ...
www.nsti.org/press/PRshow.html?id=2289 - 104k - 15 Feb 2008 - Cached - Similar pages

Tag: LIBIGEL [feeds.mn1.com]

Leading small-cap pharmaceutical company BioSante Pharmaceuticals (OTCBB: BPA) recently told Market News First about three new developments the company is looking at, and how they ...
feeds.mn1.com/tags/?/libigel - 101k - 15 Feb 2008 - Cached - Similar pages

Live Search

At International Society for the Study of Womenâ€™s Sexual Health (ISSWSH) annual meeting. ... At International Society for the Study of Womenâ€™s Sexual Health (ISSWSH) annual ...
www.live.com/?searchonly=true&mkt=de-DE - 116k - 14 Feb 2008 - Cached - Similar pages

LibiGel New Drug Application

LibiGel information from Drugs.com, includes LibiGel side effects, interactions and indications. ... LibiGel. female testosterone gel. Treatment for Female Sexual Dysfunction ...
www.drugs.com/nda/libigel_071002.html - 105k - 15 Feb 2008 - Cached - Similar pages

LibiGel

Drug's News Blog
blog.find-group.com/libigel/ - 68k - 17 Feb 2008 - Cached - Similar pages

BioSante Pharmaceuticals to Present LibiGel(R) at International ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (Amex: BPA) announced today that it has been granted a presentation at the International Society for the Study ...
www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070221005328&newsLang=en - 73k - 17 Feb 2008 - Cached - Similar pages

BioSante Pharmaceuticals To Present Validation Data Required for ...

BioSante Pharmaceuticals To Present Validation Data Required for Development of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction ...
biz.yahoo.com/bw/071004/20071004005315.html?.v=1 - 105k - 15 Feb 2008 - Cached - Similar pages

BioSante Pharmaceuticals Initiates Phase III Study of LibiGel(R ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (Amex: BPA) announced today that it has initiated a Phase III safety and efficacy trial of LibiGel
www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20061228005082&newsLang=en - 73k - 17 Feb 2008 - Cached - Similar pages

Links: